Innovative Research Award
Christophe Morisseau – University of California, Davis
| Christophe Morisseau | |
|---|---|
| Affiliation | University of California, Davis |
| Country | United States |
| Scopus ID | 7003527841 |
| Documents | 244 |
| Citations | 15,067 |
| h-index | 68 |
| Subject Area | Organic Synthesis |
| Event | World Top Scientist Awards |
| ORCID | 0000-0002-5672-6631 |
Christophe Morisseau is a researcher affiliated with the University of California, Davis and is widely recognized for contributions related to organic synthesis, enzymology, and chemical biology. His scholarly output demonstrates sustained engagement with interdisciplinary scientific research and collaborative academic activity. The volume of publications, citation performance, and research visibility indicate an established presence within the international scientific community.[1]
Contents
Abstract
This article presents a concise academic overview of Christophe Morisseau and highlights selected indicators of research productivity, scholarly influence, and scientific engagement. The profile summarizes institutional affiliation, publication activity, citation metrics, and thematic research interests. It also outlines factors relevant to academic recognition within international scientific award frameworks.[1]
Keywords
Organic Synthesis, Enzymology, Chemical Biology, Lipid Metabolism, Academic Research, Scientific Publications, Citation Impact, University of California Davis.
Introduction
Modern scientific research increasingly relies on interdisciplinary collaboration, advanced analytical methods, and long-term knowledge development. Researchers who consistently contribute to peer-reviewed literature help advance understanding within specialized domains while supporting broader scientific progress. Christophe Morisseau’s academic record reflects participation in this evolving research environment through extensive publication and citation activity.[2]
Research Profile
Research metrics associated with Christophe Morisseau indicate substantial scholarly engagement over multiple years. With hundreds of indexed documents and a significant citation record, the profile demonstrates continuing visibility within the scientific literature. These indicators are commonly used by academic institutions and professional organizations when evaluating research performance and scientific influence.[1][3]
Research Contributions
Published studies associated with Morisseau have explored biochemical pathways, enzyme mechanisms, and applications relevant to human health and molecular science. Collaborative investigations have contributed to the understanding of biologically active compounds and their interactions. Such work forms part of a broader scientific effort aimed at generating reproducible knowledge and supporting future innovation.[4][5]
Publications
Christophe Morisseau has authored and co-authored hundreds of peer-reviewed publications covering medicinal chemistry, enzymology, pharmacology, inflammation, lipid mediators, and soluble epoxide hydrolase research. His publication record demonstrates continuous collaboration with international researchers and reflects sustained contributions to experimental science and translational biomedical research.[1]
Research Impact
Bibliometric indicators demonstrate broad international recognition of Christophe Morisseau’s research activities. With more than 244 indexed publications, over 15,000 citations, and an h-index of 68, his scientific output has contributed to ongoing developments in medicinal chemistry, toxicology, and pharmaceutical sciences. These metrics illustrate continued scholarly influence across multiple research disciplines.[2]
Award Suitability
Based on publicly available academic indicators, Christophe Morisseau possesses an established publication record, sustained citation performance, extensive collaborative research, and long-term institutional engagement. Such characteristics are commonly considered during the evaluation of international scientific recognition programs. Final award decisions, however, remain the responsibility of the respective award organization and its independent review procedures.[3]
Conclusion
Christophe Morisseau has developed a distinguished academic profile through sustained contributions to chemical and biomedical research. His publication history, citation performance, editorial activities, and interdisciplinary collaborations demonstrate continued engagement with the international scientific community. This profile provides a concise overview of publicly documented academic achievements and research activities while maintaining a neutral encyclopedic presentation.[4]
External Links
References
- Xu H., Cao R., Morisseau C., et al. (2025). Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease. Journal of Medicinal Chemistry.
https://doi.org/10.1021/acs.jmedchem.5c00854 - Wagner K.M., Yang J., Morisseau C., Hammock B.D. (2025). Inhibition of Soluble Epoxide Hydrolase Prevents Docetaxel-Induced Painful Peripheral Neuropathy. International Journal of Molecular Sciences.
https://doi.org/10.3390/ijms26125630 - He Q., Pan B., Morisseau C., et al. (2024). Strategies for the Immobilization and Signal Amplification of a Double Nanobody Sandwich ELISA. Analytical Chemistry.
https://doi.org/10.1021/acs.analchem.4c04505 - Edin M.L., Morisseau C., Hammock B.D., et al. (2024). Effects of sEH Inhibition on the Eicosanoid and Cytokine Storms in SARS-CoV-2 Infected Mice. The FASEB Journal.
https://doi.org/10.1096/fj.202302202RR - Burmistrov V.V., Morisseau C., Danilov D.V., et al. (2023). Fluorine and Chlorine Substituted Adamantyl-Urea as Molecular Tools for Human Soluble Epoxide Hydrolase with Picomolar Efficacy. Journal of Enzyme Inhibition and Medicinal Chemistry.
https://doi.org/10.1080/14756366.2023.2274797